top of page

PUBLICATIONS

Peer Reviewed Publications 2024

133. N-(Benzothiazol-2-yl)-4-((5-chlorobenzoxazol-2-yl)amino)butanamide. Molbank 2024,M1854. https://doi.org/10.3390/M1854

​

130. Synthesis and biosimulation of benzimidazoles with antihypertensive multitarget effect. Bioorg. Med. Chem . Lett. 2024, 29, 2585. https://doi.org/10.1016/j.bmcl.2024.129879

129.  Imidazole Carbamates: In Vitro Effects on the Growth and Gene Expression of Trichomonas vaginalis. Molecules 2024, 29, 2585. https://doi.org/10.3390/molecules29112585

131. Arsenate Stabilization via Dynamic Covalent Chemistry. ChemistrySelect 2024, 9, 26,e202401579. https://doi.org/10.1002/slct.202401579

132. Antidiabetic drugs in Parkinson's disease. Clin Park Relat Disord. 2024;11:100265. https://doi.org/10.1016/j.prdoa.2024.100265

128.  Antinociceptive effect of LMH-2 on the neuropathic pain of diabetic mice. Biomed Pharmacother. 2024, 174:116524. https://doi.org/10.1016/j.biopha.2024.116524 

127.  Aza-Michael Additions of Benzylamine to Acrylates. Processes 2024, 12, 34. https://doi.org/10.3390/pr12010034 

134.  Discovery of Palindrome Dual PPARγ-GPR40 Agonists for Treating Type 2 Diabetes. ChemMedChem. 2024 Sep 5:e202400492.https://doi.org/10.1002/cmdc.202400492

​

135.  â€‹â€‹ Design and Synthesis of Barbiturates and Hydantoins with MultitargetAntidiabetic Effect. J. Mex. Chem. Soc. 2024, 68 (4), 609-623. https://doi.org/10.29356/jmcs.v68i4.2284

​

Peer Reviewed Publications 2023

126.  Design of a multi-target focused library for antidiabetic targets. Front. Pharmacol. 2023, 14, 1276444.  doi: https://doi.org/10.3389/fphar.2023.1276444

125. SÍNTESIS ORGÁNICA ASISTIDA POR MICROONDAS: Crónicas  de compuestos bioactivos, QUIMIOFILIA 2023,  10.56604/qfla202229QUIMLUZ4349​

124. Enhancing Giardicidal Activity and Aqueous Solubility through the Development of "RetroABZ", Int J Mol Sci. 2023, 24(19):14949. doi: https://doi.org/10.3390/ijms241914949

122.Insulin Sensitization  Mediates the Antidiabetic Effect of P. australisPharmaceuticals 2023, 16, 535. https://doi.org/10.3390/ph16040535   

​

123. LC-MS Fingerprinting Development for Standardized Precipitate from A. mexicana, Pharmaceutics. 2023, 15(9):2346. https://doi.org/10.3390/pharmaceutics15092346

​

Peer Reviewed Publications 2022

121. Giardia lamblia G6PD::6PGL Inhibitors Decrease Trophozoite Viability. Int. J. Mol. Sci. 2022, 23, 14358. https://doi.org/10.3390/ijms232214358

​

120.Synthesis, in combo hypoglycemic and lipid-lowering effects of TZD . Bioorg. Med Chem. Lett 2022, 70, 128804https://doi.org/10.1016/j.bmcl.2022.128804

 

119. Kinetic and molecular docking studies  of fused G6PD::6PGL protein from T. vaginalis. Molecules. 2022, 27(4), 1174https://doi.org/10.3390/molecules27041174

 

118.Synthesis & Antidiabetic Bioassays of 4-Nitro(thio)phenoxyisobutyric Acids as PPARγ Modulators. Pharmaceuticals 2022, 15(1), 102https://doi.org/10.3390/ph15010102 

​

117. PPARα/γ adiponectin and GLUT4 overexpression induced by moronic acid methyl ester. Can. J. Physiol.  Pharmacol. 2022,100 (4), 295-305 https://doi.org/10.1139/cjpp-2021-0526

Peer Reviewed Publications 2021

116. Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood. Biomolecules. 2021, 11 (12) 1817. https://doi.org/10.3390/biom11121817 

​

115. Identification and in silico characterization of novel H. pylori G6PDH inhibitors. Molecules. 2021, 26 (16) 4955. https://doi.org/10.3390/molecules26164955 

113. A New Symmetrical Thiazolidinedione Derivative: In Silico Design, Synthesis, and In Vivo Evaluation. Processes. 2021, 9(8), 1294  https: //doi.org/10.3390/pr9081294

114. Evaluation of the Anticonvulsant and Neuroprotective Activities of Polysaccharides from  Ganoderma. Pharmacogn J. 2021; 13 (5), 1161-1173. https://doi.org/10.5530/pj.2021.13

109. Design, Synthesis, and In Silico Multitarget Pharmacological Simulations.  Molecules 2021, 26(4), 799; https://doi.org/10.3390/molecules26040799 

108. Novel inhibitors of human glucose-6-phosphate dehydrogenase (HsG6PD).  Biochim Biophys Acta Gen Subj. 2021;1865(3):129828 https://doi.org/10.1016/j.bbagen.2020.129828

Peer Reviewed Publications 2020

107. Toxicological Screening of Four Bioactive Citroflavonoids: In combo Approaches.  Molecules. 2020; 25(24):5959   https://doi.org/10.3390/molecules25245959

106. Pharmacological characterization of the cardiovascular effect of Nibethione. J.  Pharm. & Pharmacol. 2020, 72(9), 1186-1198 https://doi.org/10.1111/jphp.13295

105. Novel CB1R antagonist modifies pancreatic islet function in prediabetic and diabetic mice. Nutr. Diabetes 2020, 10, 7. https://www.nature.com/articles/s41387-020-0110-0

​

104. Metronidazole and Secnidazole Carbamates. Molecules. 2020, 25793.   https://www.mdpi.com/1420-3049/25/4/793

102. A haloperidol analog that reduces neuropathic nociception via σ1 receptor antagonism. Life Sci. 2020, 245, 117348.   https://doi.org/10.1016/j.lfs.2020.117348

101. Antidiabetic effect of Cordia morelosana, chemical and pharmacological studies. J. Ethnopharm. 2020, 251, 112543.   https://doi.org/10.1016/j.jep.2020.112543

Peer Reviewed Publications 2019

100. Design, synthesis, antihyperglycemic studies & docking  of benzimidazole-thiazolidinedione hybrids. J. Chem. 2019, 1650145.   https://doi.org/10.1155/2019/1650145s

99. Molecular Docking and Dynamics Simulation of Protein β-Tubulin and Antifungal Cyclic Lipopeptides: Molecules https://doi.org/10.3390/molecules24183387

98. Functional relaxant effect of 6,7-dipropoxy-2H-chromen-2-one: Med. Chem. Res.  https://link.springer.com/article/10.1007/s00044-019-02364-y

97.Antidiabetic inclusion complexes: J. Chem. Thermodyn. https://doi.org/10.1016/j.jct.2018.09.01

96. Triterpenoids from H. sabdariffa L. as PPARδ/γ Dual Agonist. Planta Medica  https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-0824-1316
Peer Reviewed Publications 2018
Peer Reviewed Publications 2017
bottom of page